Journal of Angiotherapy Impact Factor in Pharmaceutics Journals

Journal of Angiotherapy in Pharmaceutics Journals

Journal Country: Australia
Journal Q tier: Q3
Publishing Firm: Eman Research
History: 2021-2022
Journal Homepage: ----
Journal ISSN: 22078843, 2207872X

Research Categories

Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4)

Impact Score: 1
h-Index: 2
SJR: 0.158
Ranking: 21472

About Journal of Angiotherapy

Journal of Angiotherapy is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4). It is published by Eman Research. The overall rank of Journal of Angiotherapy is 21472.According to SCImago Journal Rank (SJR), this journal is ranked 0.158. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 2. The best quartile for this journal is Q3.The ISSN of Journal of Angiotherapy journal is 22078843, 2207872X.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Angiotherapy is cited by a total of 8 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.